Konstrukcija i modeliranje kolekcije luksuznog ženskog donjeg rublja

Inspiraciju za pisanje ovoga dijela dobila sam na jednom od predavanja profesorice Vinković, gdje sam otkrila da donje rublje uglavnom uzimamo zdravo za gotovo, a zapravo je on glavni segment odijevanja. Činjenica je da jako malo znamo o njemu, te sam se motivirala da krenem u istraživanje. Krenula sam od samoga početka pojavljivanja donjeg rublja u povijesti, te njegov razvoj kroz stoljeća do današnjeg oblika kojeg svi volimo i nosimo. Došla sam na jednu poduzetničku ideju da, možda moje buduće zanimanje bude dizajnerica donjeg rublja, te sam istražila sve marketinške segmente kako bi možda jednog dana ostvarila i realizirala svoju želju o dizajnu luksuznog donjeg rublja. Kako bi se to ostvarilo treba imati i neku ideju što i kako raditi. U ovome radu sam opisala svaki segment razvijanja kolekcije i brenda luksuznog donjeg rublja

Launching a New Brand of Women’s Underwear

Women’s underwear plays a significant role in everyday clothing. Underwear serves a number of equally important purposes. High aesthetic requirements have to be fulfilled as well as those of protection and comfort. Therefore, the idea of launching a new fashion brand of women’s underwear is presented in this paper. The main purpose of the paper is the description of the development of a new brand of luxury underwear including the introduction of several economic phases which are cover mission, vision, brand goal, SWOT analysis and 7P marketing mix

Masivna tromboza abdominalne aorte s distalnom embolijom kao jedina klinička manifestacija COVID-19 infekcije

COVID-19 infection usually presents with respiratory symptoms and fever however several unusual initial presentations of this infection were reported in literature. We report a case of arterial thrombosis as a presenting features of this disease without any other COVID-19-related symptoms. This might lead to delayed COVID-19 diagnosis and isolation of suspected patient causing epidemiologic consequences and increased risk of transmission of the virus inside the hospital in time of pandemic unless timely recognized.Infekcija COVID-19 se obično manifestira respiratornim simptomima i vrućicom, no u literaturi je opisano nekoliko neuobi-čajenih početnih simptoma bolesti. Prikazujemo slučaj bolesnice s trombozom arterije kao jedinom kliničkom prezentacijom ove bolesti, bez drugih uobičajenih simptoma vezanih uz COVID-19. Ukoliko se pravovremeno ne prepozna, to može rezultirati odgo-đenim dijagnosticiranjem i izolacijom suspektnog bolesnika te uzrokovati epidemiološke posljedice i povećani rizik prijenosa virusa unutar bolnice u doba pandemije

The applicability of magnetic resonance imaging classification system (MRICS) for cerebral palsy and its association with perinatal factors and related disabilities in a Croatian population-based sample

Aim To investigate the association of cerebral palsy motor disorders, perinatal factors, and related disabilities with brain magnetic resonance imaging classification score (MRICS)-based groups in a population-based sample. Methods The study enrolled children with cerebral palsy born from 2003 to 2015 treated at Split University Hospital who underwent brain MRI scanning. Perinatal data (plurality, birth weight, gestational age, and Apgar score) were collected from hospital records. Motor disorders of cerebral palsy (gross and fine motor function) and the related disabilities (intellectual status, speech and eating ability, epilepsy, vision and hearing status) were evaluated with neurological status assessment. Neuroimaging findings were presented as MRICS-based groups. Results Of 115 enrolled children, an abnormal finding on brain MRI was confirmed in 95%, including white matter injury (66%), maldevelopments (13.9%), gray matter injury (9.6%), and miscellaneous findings (6.1%). Gross and fine motor function were not significantly associated with MRICS-based group. All related disabilities and perinatal factors, except Apgar score, were significantly associated with MRICS-based group. Conclusion Brain MRICS-based groups were associated with perinatal risk factors and related disabilities of cerebral palsy, but not with common motor disorders. MRI classification score is a reliable diagnostic tool, which strongly correlates with perinatal factors and related disabilities of cerebral pals

THE IMPORTANCE OF DETERMINING THE FIVE GENES - THROMBOPHILIA PANEL ON A THERAPEUTICAL CHOICE FOR WOMEN WITH RECURRENT ABORTIONS, MISCARRIAGES AND STERILITY : CROSS-SECTIONAL STUDY

Cilj ovog istraživanja bio je utvrditi prisutnost i učestalost mutacija u genima za Faktor V, Faktor II, MTHFR, PAI-1 i ACE čije su mutacije važne u patologiji koagulacije krvi. Također, u cilju nam je bilo utvrditi povezanost određenih mutacija gena s uputnim dijagnozama (abortus habitualis, abortus spontaneus, izostali pobačaj, sterilitas i graviditas abnormalis). Analizirano je ukupno 505 uzoraka krvi pacijentica s navedenim dijagnozama. Od cjelokupnog broja, analizirano je 500 uzoraka za Faktor V i Faktor II, 505 uzoraka za MTHFR, 504 uzorka za PAI-1 i 499 uzoraka za ACE. Utvrđeno je kako je heterozigotni genotip za Faktor V imalo 5,6% (28/500) ispitanica. Heterozigotni genotip za Faktor II imalo je 3,2% (16/500) ispitanica, dok je mutirani, homozigotni genotip imalo njih 0,2% (1/500). Heterozigotni genotip za MTHFR utvrđen je u 44,4% (224/505) ispitanica, dok je mutirani, homozigotni genotip utvrđen u njih 13,6% (69/505). Delecijski, homozigotni polimorfizam (DD) za PAI-1 utvrđen je u 28,2% (142/504), insercijsko-delecijski (ID) u 50,6%, a insercijski polimorfizam (II) u 21,2% (107/504) ispitanica. Delecijski, homozigotni polimorfizam (DD) za ACE prisutan je u 30,9% (154/499) ispitanica, insercijsko-delecijski polimorfizam (II) u 47,3% (236/499), a insercijski polimorfizam (II) u 21,8% (109/499) ispitanica. Statistički značajna razlika, između naših rezultata i onih u radu Fatinija i suradnika, utvrđena je za homozigotni, delecijski genotip (DD) gena za ACE (P=0,019). Iako nije utvrđena statistički značajna povezanost između određenih mutacija gena i uputnih dijagnoza, čini se da je molekularna DNA analiza tih mutacija važna u dijagnostici, odabiru terapije poremećaja zgrušavanja krvi i spriječavanju gubitaka trudnoća koje su uzrokovane tim poremećajima.OBJECTIVES: The aim of this study was to determine the presence and prevalence of mutations in genes for Factor V, Factor II, MTHFR, PAI-1 and ACE, as well as the linkage between mutations of these genes with advisable diagnosis (recurrent abortion, spontaneous abortion, missed abortion, sterilitas and abnormal pregnancy). PATIENTS AND METHODS: All the analyses were performed in the Laboratory for Molecular Genetics in Split, during the period from 2007. and 2012. A total of 505 blood samples of women (age 18-45) who suffered recurrent abortions, missed abortions, spontaneous abortions, sterility and abnormal pregnancy were analysed for Factor V, Factor II, MTHFR, PAI-1 and ACE. RESULTS: The prevalence of heterozygous mutations for Factor V was 5,6%. The prevalence of heterozygous mutations for Factor II was 3,2% while the prevalence of mutated, homozygous mutations for Factor II was observed in 0,2% of subjects. The prevalence of heterozygous mutations for MTHFR was 44,4% and the prevalence of mutated, homozygous mutations for MTHFR was observed in 13,6% of women. The deletion polymorphism for PAI-1 was determined in 28,2% of subjects, an insertion-deletion polymorphism in 50,6% of subjects, while an insertion polymorphism was shown in 21,2% of subjects. The deletion polymorphism for ACE was determined in 30,9% patients, an insertion-deletion polymorphism in 47,3% patients, while an insertion polymorphism was shown in 21,8% of subjects. The frequency of deletion polymorphism (DD) of ACE gene was significantly different between our results and the results from literature (P=0,019). Other results suggest that the prevalence of mutations for Factor V, Factor II, MTHFR and PAI-1 in the tested group of women was similar to those in other studies

THE IMPORTANCE OF DETERMINING THE FIVE GENES - THROMBOPHILIA PANEL ON A THERAPEUTICAL CHOICE FOR WOMEN WITH RECURRENT ABORTIONS, MISCARRIAGES AND STERILITY : CROSS-SECTIONAL STUDY

Cilj ovog istraživanja bio je utvrditi prisutnost i učestalost mutacija u genima za Faktor V, Faktor II, MTHFR, PAI-1 i ACE čije su mutacije važne u patologiji koagulacije krvi. Također, u cilju nam je bilo utvrditi povezanost određenih mutacija gena s uputnim dijagnozama (abortus habitualis, abortus spontaneus, izostali pobačaj, sterilitas i graviditas abnormalis). Analizirano je ukupno 505 uzoraka krvi pacijentica s navedenim dijagnozama. Od cjelokupnog broja, analizirano je 500 uzoraka za Faktor V i Faktor II, 505 uzoraka za MTHFR, 504 uzorka za PAI-1 i 499 uzoraka za ACE. Utvrđeno je kako je heterozigotni genotip za Faktor V imalo 5,6% (28/500) ispitanica. Heterozigotni genotip za Faktor II imalo je 3,2% (16/500) ispitanica, dok je mutirani, homozigotni genotip imalo njih 0,2% (1/500). Heterozigotni genotip za MTHFR utvrđen je u 44,4% (224/505) ispitanica, dok je mutirani, homozigotni genotip utvrđen u njih 13,6% (69/505). Delecijski, homozigotni polimorfizam (DD) za PAI-1 utvrđen je u 28,2% (142/504), insercijsko-delecijski (ID) u 50,6%, a insercijski polimorfizam (II) u 21,2% (107/504) ispitanica. Delecijski, homozigotni polimorfizam (DD) za ACE prisutan je u 30,9% (154/499) ispitanica, insercijsko-delecijski polimorfizam (II) u 47,3% (236/499), a insercijski polimorfizam (II) u 21,8% (109/499) ispitanica. Statistički značajna razlika, između naših rezultata i onih u radu Fatinija i suradnika, utvrđena je za homozigotni, delecijski genotip (DD) gena za ACE (P=0,019). Iako nije utvrđena statistički značajna povezanost između određenih mutacija gena i uputnih dijagnoza, čini se da je molekularna DNA analiza tih mutacija važna u dijagnostici, odabiru terapije poremećaja zgrušavanja krvi i spriječavanju gubitaka trudnoća koje su uzrokovane tim poremećajima.OBJECTIVES: The aim of this study was to determine the presence and prevalence of mutations in genes for Factor V, Factor II, MTHFR, PAI-1 and ACE, as well as the linkage between mutations of these genes with advisable diagnosis (recurrent abortion, spontaneous abortion, missed abortion, sterilitas and abnormal pregnancy). PATIENTS AND METHODS: All the analyses were performed in the Laboratory for Molecular Genetics in Split, during the period from 2007. and 2012. A total of 505 blood samples of women (age 18-45) who suffered recurrent abortions, missed abortions, spontaneous abortions, sterility and abnormal pregnancy were analysed for Factor V, Factor II, MTHFR, PAI-1 and ACE. RESULTS: The prevalence of heterozygous mutations for Factor V was 5,6%. The prevalence of heterozygous mutations for Factor II was 3,2% while the prevalence of mutated, homozygous mutations for Factor II was observed in 0,2% of subjects. The prevalence of heterozygous mutations for MTHFR was 44,4% and the prevalence of mutated, homozygous mutations for MTHFR was observed in 13,6% of women. The deletion polymorphism for PAI-1 was determined in 28,2% of subjects, an insertion-deletion polymorphism in 50,6% of subjects, while an insertion polymorphism was shown in 21,2% of subjects. The deletion polymorphism for ACE was determined in 30,9% patients, an insertion-deletion polymorphism in 47,3% patients, while an insertion polymorphism was shown in 21,8% of subjects. The frequency of deletion polymorphism (DD) of ACE gene was significantly different between our results and the results from literature (P=0,019). Other results suggest that the prevalence of mutations for Factor V, Factor II, MTHFR and PAI-1 in the tested group of women was similar to those in other studies

THE IMPORTANCE OF DETERMINING THE FIVE GENES - THROMBOPHILIA PANEL ON A THERAPEUTICAL CHOICE FOR WOMEN WITH RECURRENT ABORTIONS, MISCARRIAGES AND STERILITY : CROSS-SECTIONAL STUDY

Cilj ovog istraživanja bio je utvrditi prisutnost i učestalost mutacija u genima za Faktor V, Faktor II, MTHFR, PAI-1 i ACE čije su mutacije važne u patologiji koagulacije krvi. Također, u cilju nam je bilo utvrditi povezanost određenih mutacija gena s uputnim dijagnozama (abortus habitualis, abortus spontaneus, izostali pobačaj, sterilitas i graviditas abnormalis). Analizirano je ukupno 505 uzoraka krvi pacijentica s navedenim dijagnozama. Od cjelokupnog broja, analizirano je 500 uzoraka za Faktor V i Faktor II, 505 uzoraka za MTHFR, 504 uzorka za PAI-1 i 499 uzoraka za ACE. Utvrđeno je kako je heterozigotni genotip za Faktor V imalo 5,6% (28/500) ispitanica. Heterozigotni genotip za Faktor II imalo je 3,2% (16/500) ispitanica, dok je mutirani, homozigotni genotip imalo njih 0,2% (1/500). Heterozigotni genotip za MTHFR utvrđen je u 44,4% (224/505) ispitanica, dok je mutirani, homozigotni genotip utvrđen u njih 13,6% (69/505). Delecijski, homozigotni polimorfizam (DD) za PAI-1 utvrđen je u 28,2% (142/504), insercijsko-delecijski (ID) u 50,6%, a insercijski polimorfizam (II) u 21,2% (107/504) ispitanica. Delecijski, homozigotni polimorfizam (DD) za ACE prisutan je u 30,9% (154/499) ispitanica, insercijsko-delecijski polimorfizam (II) u 47,3% (236/499), a insercijski polimorfizam (II) u 21,8% (109/499) ispitanica. Statistički značajna razlika, između naših rezultata i onih u radu Fatinija i suradnika, utvrđena je za homozigotni, delecijski genotip (DD) gena za ACE (P=0,019). Iako nije utvrđena statistički značajna povezanost između određenih mutacija gena i uputnih dijagnoza, čini se da je molekularna DNA analiza tih mutacija važna u dijagnostici, odabiru terapije poremećaja zgrušavanja krvi i spriječavanju gubitaka trudnoća koje su uzrokovane tim poremećajima.OBJECTIVES: The aim of this study was to determine the presence and prevalence of mutations in genes for Factor V, Factor II, MTHFR, PAI-1 and ACE, as well as the linkage between mutations of these genes with advisable diagnosis (recurrent abortion, spontaneous abortion, missed abortion, sterilitas and abnormal pregnancy). PATIENTS AND METHODS: All the analyses were performed in the Laboratory for Molecular Genetics in Split, during the period from 2007. and 2012. A total of 505 blood samples of women (age 18-45) who suffered recurrent abortions, missed abortions, spontaneous abortions, sterility and abnormal pregnancy were analysed for Factor V, Factor II, MTHFR, PAI-1 and ACE. RESULTS: The prevalence of heterozygous mutations for Factor V was 5,6%. The prevalence of heterozygous mutations for Factor II was 3,2% while the prevalence of mutated, homozygous mutations for Factor II was observed in 0,2% of subjects. The prevalence of heterozygous mutations for MTHFR was 44,4% and the prevalence of mutated, homozygous mutations for MTHFR was observed in 13,6% of women. The deletion polymorphism for PAI-1 was determined in 28,2% of subjects, an insertion-deletion polymorphism in 50,6% of subjects, while an insertion polymorphism was shown in 21,2% of subjects. The deletion polymorphism for ACE was determined in 30,9% patients, an insertion-deletion polymorphism in 47,3% patients, while an insertion polymorphism was shown in 21,8% of subjects. The frequency of deletion polymorphism (DD) of ACE gene was significantly different between our results and the results from literature (P=0,019). Other results suggest that the prevalence of mutations for Factor V, Factor II, MTHFR and PAI-1 in the tested group of women was similar to those in other studies

Suor Angelica et autres sœurs (komorni ansambl i solisti Muzičke akademije u Zagrebu, 12.2.2021.)

Snimka izvedbe održane na Muzičkoj akademiji u Koncertnoj dvorani "Blagoje Bersa" 12.2.2021. Na projektu postavljanja opere sudjelovale su četiri sastavnice Sveučilišta u Zagrebu: Muzička akademija, Akademija dramske umjetnosti, Akademija likovnih umjetnosti i Fakultet strojarstva i brodogradnje. Izvođači: studenti solo pjevanja: Nela Katalenić Klinar, Lucija Ercegovac, Emilija Rukavina, Tea Zec, Maja Sremec, Neža Vasle, Martina Barišić, Stefani Pijetlović, Darija Auguštan, Laura Marincel Haller, Josipa Bilić, Barbara Pijetlović, Marija Jurić; komorni ansambl: Barbara Tomić (flauta, piccolo), Andrea Pedron (udaraljke), Petra Barišić (harfa), Ellen Široka (harfa), Dubravko Ćepulić Polgar (orgulje), Ivana Hrkać (pozitiv), Marko Glogović (violina), Edita Kolovrat (violina), Filip Kojundžić (viola), Lana-Lucija Horvatić (violončelo); umjetničko vodstvo: Mladen Tarbuk; dirigent: Mateo Narančić; redatelj: Matthias Behrends. Program: Suor Angelica et autres sœurs, pasticcio-opera sastavljena od glazbe skladatelja različitih stilskih razdoblja (Puccini, Poulenc, Mozart, Barber, Klose, Hindemith, Hildegard von Bingen, Caplet, Tarbuk, Ravel) prema romanu Veronike Peters "Što sve stane u dva kofera"

Suor Angelica et autres sœurs (komorni ansambl i solisti Muzičke akademije u Zagrebu, 11.2.2021.)

Snimka izvedbe održane na Muzičkoj akademiji u Koncertnoj dvorani "Blagoje Bersa" 11.2.2021. Na projektu postavljanja opere sudjelovale su četiri sastavnice Sveučilišta u Zagrebu: Muzička akademija, Akademija dramske umjetnosti, Akademija likovnih umjetnosti i Fakultet strojarstva i brodogradnje. Izvođači: studenti solo pjevanja: Marija Salečić, Marko Antolković, Ines Grubišić, Lucija Klarić, Maja Sremec, Neža Vasle, Vlatka Kladarić, Lucija Ercegovac, Stefani Pijetlović, Patricija Žudetić, Tea Zec, Ana Majdak, Petra Cik, Barbara Pijetlović; komorni ansambl: Barbara Tomić (flauta, piccolo), Andrea Pedron (udaraljke), Petra Barišić (harfa), Ellen Široka (harfa), Dubravko Ćepulić Polgar (orgulje), Ivana Hrkać (pozitiv), Marko Glogović (violina), Edita Kolovrat (violina), Filip Kojundžić (viola), Lana-Lucija Horvatić (violončelo); umjetničko vodstvo: Mladen Tarbuk; dirigent: Mateo Narančić; redatelj: Matthias Behrends. Program: Suor Angelica et autres sœurs, pasticcio-opera sastavljena od glazbe skladatelja različitih stilskih razdoblja (Puccini, Poulenc, Mozart, Barber, Klose, Hindemith, Hildegard von Bingen, Caplet, Tarbuk, Ravel) prema romanu Veronike Peters "Što sve stane u dva kofera"

Suor Angelica et autres sœurs (komorni ansambl i solisti Muzičke akademije Sveučilišta u Zagrebu, 11. 2. 2021.)

Snimka izvedbe održane na Muzičkoj akademiji u Koncertnoj dvorani "Blagoje Bersa" 11. 2. 2021. Na projektu postavljanja opere sudjelovale su četiri sastavnice Sveučilišta u Zagrebu: Muzička akademija, Akademija dramske umjetnosti, Akademija likovnih umjetnosti i Fakultet strojarstva i brodogradnje. Izvođači: studenti solo pjevanja (Marija Salečić, Marko Antolković, Ines Grubišić, Lucija Klarić, Maja Sremec, Neža Vasle, Vlatka Kladarić, Lucija Ercegovac, Stefani Pijetlović, Patricija Žudetić, Tea Zec, Ana Majdak, Petra Cik, Barbara Pijetlović), komorni ansambl (Barbara Tomić (flauta, piccolo), Andrea Pedron (udaraljke), Petra Barišić (harfa), Ellen Široka (harfa), Dubravko Ćepulić Polgar (orgulje), Ivana Hrkać (pozitiv), Marko Glogović (violina), Edita Kolovrat (violina), Filip Kojundžić (viola), Lana-Lucija Horvatić (violončelo)). Umjetničko vodstvo: red. prof. art. Mladen Tarbuk. Dirigent: Mateo Narančić. Redatelj: Matthias Behrends. Program: Suor Angelica et autres sœurs, pasticcio-opera sastavljena od glazbe skladatelja različitih stilskih razdoblja (Puccini, Poulenc, Mozart, Barber, Klose, Hindemith, Hildegard von Bingen, Caplet, Tarbuk, Ravel) prema romanu Veronike Peters "Što sve stane u dva kofera"